733 related articles for article (PubMed ID: 26470614)
1. Hidradenitis suppurativa: Epidemiology and scope of the problem.
Jemec GB; Kimball AB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Denny G; Anadkat MJ
J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
[No Abstract] [Full Text] [Related]
4. Systemic associations of hidradenitis suppurativa.
Kohorst JJ; Kimball AB; Davis MD
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S27-35. PubMed ID: 26470611
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center.
Patel M; Cohen JM; Wright NA; Merola JF; Qureshi AA; Vleugels RA
J Am Acad Dermatol; 2015 Oct; 73(4):701-2. PubMed ID: 26369843
[No Abstract] [Full Text] [Related]
7. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
Goldburg SR; Strober BE; Payette MJ
J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features.
Wang SC; Wang SC; Sibbald RG; Alhusayen R; Bashash M; Alavi A
Adv Skin Wound Care; 2015 Jul; 28(7):325-32; quiz 333-4. PubMed ID: 26080019
[TBL] [Abstract][Full Text] [Related]
11. Color Doppler ultrasound assessment of morphology and types of fistulous tracts in hidradenitis suppurativa (HS).
Wortsman X; Castro A; Figueroa A
J Am Acad Dermatol; 2016 Oct; 75(4):760-767. PubMed ID: 27498279
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic and clinical features of hidradenitis suppurativa.
Parulkar I; Haleem H; Paek SY
Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
[TBL] [Abstract][Full Text] [Related]
13. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
14. Laser and light-based treatment options for hidradenitis suppurativa.
Hamzavi IH; Griffith JL; Riyaz F; Hessam S; Bechara FG
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S78-81. PubMed ID: 26470622
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
16. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
Preda-Naumescu A; Ahmed HN; Mayo TT; Yusuf N
Int J Dermatol; 2021 Nov; 60(11):e449-e458. PubMed ID: 33890304
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Vekic DA; Frew J; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
[TBL] [Abstract][Full Text] [Related]
18. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
19. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System.
Kokolakis G; Wolk K; Schneider-Burrus S; Kalus S; Barbus S; Gomis-Kleindienst S; Sabat R
Dermatology; 2020; 236(5):421-430. PubMed ID: 32610312
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
